Transgene Biotek LimitedBSE: TRABI

Board Meeting Outcome for Outcome Of Board Meeting - Scrip Code 526139

· Issued by Transgene Biotek Limited via BSE India

Filed with BSE ·

This has reference to our letter dated January 16 2025.1) The Board has considered and approved the unaudited Consolidated & Standalone Financial Results of the company, for the Quarter ended 31.12.2024 in accordance with the Indian Accounting Standards (IND-AS) as per Companies (Indian Accounting Standards) Rules, 2015.2) Limited Review Report on the Unaudited Standalone and Consolidated Financial Results of the Company, for the quarter ended 31.12.2024 has also been approved.3) The Board has discussed and approved a funding proposal to raise funds on asecuritized basis to address the pressing demands on the company and passedappropriate resolution to move the proposal forward.The meeting commenced at 11:00 a.m. and concluded at 12:25 p.m.

View Attachment

6ix hasn’t read this filing yet.

View original source (BSE India)Transgene Biotek Limited on 6ix

Earlier from Transgene Biotek

Later from Transgene Biotek

All Transgene Biotek news releases